News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Where the Deals are...Cancer Remains Hot


5/31/2012 8:26:53 AM

Tracking dealmaking in biopharma is more than a pastime, of course. Discerning trends is necessary for knowing where to focus and when to strike. And so a new analysis by Deloitte of hundreds of deals last year, which involved products and platform technologies, may provide some clues as to where the money and work will be directed going forward. The report looked at 714 licensing deals and joint ventures, although only 245 disclosed deal size or upfront payments.

Read at Pharmalot


comments powered by Disqus
Pharmalot
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES